1. Aman, M. G., Lam, K. S., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33(5), 527–534.
2. Anderson, C. M., & Long, E. S. (2002). Use of a structured descriptive assessment methodology to identify variables affecting problem behavior. Journal of Applied Behavior Analysis, 35(2), 137–154. https://doi.org/10.1901/jaba.2002.35-137
3. Association for Behavior Analysis International (1989). Statement on the right to effective behavioral treatment. https://www.abainternational.org/about-us/policies-and-positions/right-to-effective-behavioral-treatment,-1989.aspx
4. Association for Behavior Analysis International (2010). Statement on restraint and seclusion. https://www.abainternational.org/about-us/policies-and-positions/restraint-and-seclusion,-2010.aspx
5. Association for Behavior Analysis International (2022a). CESS task force report. https://www.abainternational.org/about-us/organizational-chart/cess-task-force/cess-position-statement-commentary/report.aspx